5-Amino-1MQ is not a peptide but a membrane-permeable small molecule with a very specific job: inhibiting nicotinamide N-methyltransferase, or NNMT.
Why NNMT Matters
NNMT consumes nicotinamide — a precursor the cell would otherwise recycle into NAD+ — and burns methyl groups in the process. The enzyme is expressed most heavily in endocrine tissue, and elevated NNMT activity appears repeatedly in metabolic dysfunction literature. Inhibiting it, in principle, preserves both NAD+ precursors and methylation capacity.
What Preclinical Work Examines
Published studies focus on adipocyte metabolism: cellular energy expenditure, adipocyte size and lipid handling, and downstream NAD+-dependent signaling. The compound gives laboratories a clean pharmacological handle on a single enzyme node inside a complex metabolic network.
The NAD+ Connection
5-Amino-1MQ research naturally complements direct NAD+ studies and mitochondrial work with MOTS-C — three angles on the same energy-metabolism axis, all in our Anti-Aging and General Health collections.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.
